Glycolaldehyde dimer

CAS No. 23147-58-2

Glycolaldehyde dimer( 14-Dioxane-25-diol | Hydroxyacetaldehyde dimer | 25-Dihydroxy-14-dioxane )

Catalog No. M19580 CAS No. 23147-58-2

Glycoaldehyde Dimer is derivative of glycolaldehyde which is the precursor molecule of various significant compounds including amino acid glycine and in the formose reaction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glycolaldehyde dimer
  • Note
    Research use only, not for human use.
  • Brief Description
    Glycoaldehyde Dimer is derivative of glycolaldehyde which is the precursor molecule of various significant compounds including amino acid glycine and in the formose reaction.
  • Description
    Glycoaldehyde Dimer is derivative of glycolaldehyde which is the precursor molecule of various significant compounds including amino acid glycine and in the formose reaction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    14-Dioxane-25-diol | Hydroxyacetaldehyde dimer | 25-Dihydroxy-14-dioxane
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23147-58-2
  • Formula Weight
    120.1
  • Molecular Formula
    C4H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    OC1COC(O)CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • c(Bua-Cpa-Thi-Val-As...

    c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.

  • 2,3-Dehydrokievitone

    2,3- Dehydrokievitone exhibits strong cytotoxic activity and induces apoptosis efficiently in cancer cells.

  • Lingdolinurad

    Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia or gout.